Plenaxis

Plenaxis Uses, Dosage, Side Effects, Food Interaction and all others data.

Synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). It is marketed by Praecis Pharmaceuticals as Plenaxis. Praecis announced in June 2006 that it was voluntarily withdrawing the drug from the market.

Used in the palliative treatment of advanced prostate cancer. Plenaxis is a luteinizing hormone agonist that results in suppression of testicular or follicular steroidogenesis.

Trade Name Plenaxis
Availability Discontinued
Generic Abarelix
Abarelix Other Names Abarelix
Related Drugs estradiol, Premarin, Xtandi, Casodex, Zytiga, Lynparza
Type
Formula C72H95ClN14O14
Weight Average: 1416.09
Monoisotopic: 1414.6840715
Protein binding

96-99%

Groups Approved, Investigational, Withdrawn
Therapeutic Class
Manufacturer EuroCept
Available Country United States, Netherlands,
Last Updated: September 19, 2023 at 7:00 am
Plenaxis
Plenaxis

Uses

For palliative treatment of advanced prostate cancer.

How Plenaxis works

Plenaxis binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion.

Toxicity

The maximum tolerated dose of abarelix has not been determined. The maximum dose used in clinical studies was 150 mg. There have been no reports of accidental overdose with abarelix.

Elimination Route

Following IM administration of 100 mg, abarelix is absorbed slowly with a mean peak concentration of 43.4 ng/mL observed approximately 3 days after the injection.

Half Life

13.2 ± 3.2 days

Innovators Monograph

You find simplified version here Plenaxis

*** Taking medicines without doctor's advice can cause long-term problems.
Share